WCN26-6355 Renoprotective Effects of Angiotensin Receptor–Neprilysin Inhibitor (ARNI) in Patients with Chronic Kidney Disease (CKD)

Read full text Summarise with VIRAT
Authors: Akio Namikawa, Daiki Yoshino, Sayako Ikeda, Dai Sato, Yoshitaka Furuto, Yuko Shibuya
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Despite the established cardiovascular benefits of ARNI, its renoprotective effects in chronic kidney disease (CKD) have not been fully elucidated. We investigated its effects on blood pressure (BP), eGFR slope, and proteinuria in hypertensive CKD patients.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Renin-Angiotensin System Studies Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105757–105757
Publication date
25 March 2026
Language
EN